I am writing the 4th ed. of my Handbook for Somatosensory Rehabilitation of Neuropathic Pain. I am wondering if I should add a section about palmitoylethanolamide (PEA). What is your experience?
My experience is positive: allows to decrease the doses of other drugs (opioids, for example), it acts on neuroinflammation. As the molecule has still vast unexplored areas
I use pea exstensively since 1995. My personal field of action is in Chronic not oncological pain. Let me know if you are interested for a paper about pea and this issue. With my best regard